NYMX(Delisted)
Nymox Pharmaceutical·NASDAQ
--
--(--)
NYMX Filings
Filing Date
Form Description
Form Type
2025-11-07
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-07 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-22
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-22 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-22
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-22 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-09-23
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-09-23 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-06-03
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Financials
2025-06-03 · Financials
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025-05-22
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-05-22 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-05-01
Form NT 20-F - Notification of inability to timely file Form 20-F
2025-05-01 ·
Form NT 20-F - Notification of inability to timely file Form 20-F
2025-03-11
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-03-11 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-01-02
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-01-02 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2024-12-17
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2024-12-17 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
